Literature DB >> 15858803

Addiction in Parkinson's disease: impact of subthalamic nucleus deep brain stimulation.

Tatiana Witjas1, Christelle Baunez, Jean Marc Henry, Marie Delfini, Jean Regis, André Ali Cherif, Jean Claude Peragut, Jean Philippe Azulay.   

Abstract

In Parkinson's disease, dopamine dysregulation syndrome (DDS) is characterized by severe dopamine addiction and behavioral disorders such as manic psychosis, hypersexuality, pathological gambling, and mood swings. Here, we describe the case of 2 young parkinsonian patients suffering from disabling motor fluctuations and dyskinesia associated with severe DDS. In addition to alleviating the motor disability in both patients, subthalamic nucleus (STN) deep brain stimulation greatly reduced the behavioral disorders as well as completely abolished the addiction to dopaminergic treatment. Dopaminergic addiction in patients with Parkinson's disease, therefore, does not constitute an obstacle to high-frequency STN stimulation, and this treatment may even cure the addiction. Copyright 2005 Movement Disorder Society

Entities:  

Mesh:

Year:  2005        PMID: 15858803     DOI: 10.1002/mds.20501

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  45 in total

1.  High frequency stimulation of the subthalamic nucleus modulates neurotransmission in limbic brain regions of the rat.

Authors:  Christine Winter; Christoph Lemke; Reinhard Sohr; Wassilios Meissner; Daniel Harnack; Georg Juckel; Rudolf Morgenstern; Andreas Kupsch
Journal:  Exp Brain Res       Date:  2007-10-26       Impact factor: 1.972

Review 2.  Deep brain stimulation for the treatment of addiction: basic and clinical studies and potential mechanisms of action.

Authors:  R Christopher Pierce; Fair M Vassoler
Journal:  Psychopharmacology (Berl)       Date:  2013-08-02       Impact factor: 4.530

3.  Reducing the desire for cocaine with subthalamic nucleus deep brain stimulation.

Authors:  Tiphaine Rouaud; Sylvie Lardeux; Nicolas Panayotis; Dany Paleressompoulle; Martine Cador; Christelle Baunez
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-28       Impact factor: 11.205

Review 4.  Deep brain stimulation for Parkinson's disease.

Authors:  Patricia Limousin; Irene Martinez-Torres
Journal:  Neurotherapeutics       Date:  2008-04       Impact factor: 7.620

5.  Effect of globus pallidus internus stimulation on neuronal activity in the pedunculopontine tegmental nucleus in the primate model of Parkinson's disease.

Authors:  Jianyu Zhang; Zhong I Wang; Kenneth B Baker; Jerrold L Vitek
Journal:  Exp Neurol       Date:  2011-07-29       Impact factor: 5.330

6.  Targeting the subthalamic nucleus in a preclinical model of alcohol use disorder.

Authors:  Yann Pelloux; Christelle Baunez
Journal:  Psychopharmacology (Berl)       Date:  2017-04-11       Impact factor: 4.530

Review 7.  Deep brain stimulation for the treatment of drug addiction.

Authors:  Tony R Wang; Shayan Moosa; Robert F Dallapiazza; W Jeffrey Elias; Wendy J Lynch
Journal:  Neurosurg Focus       Date:  2018-08       Impact factor: 4.047

Review 8.  [Repetitive impulse-associated behavioral disorders in Parkinson's disease].

Authors:  R Katzenschlager; K S Goerlich; T van Eimeren
Journal:  Nervenarzt       Date:  2012-12       Impact factor: 1.214

Review 9.  Behavioural adverse effects of dopaminergic treatments in Parkinson's disease: incidence, neurobiological basis, management and prevention.

Authors:  Angelo Antonini; Roberto Cilia
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

10.  Valproate as a treatment for dopamine dysregulation syndrome (DDS) in Parkinson's disease.

Authors:  Ashok Sriram; Herbert E Ward; Anhar Hassan; Sanjay Iyer; Kelly D Foote; Ramon L Rodriguez; Nikolaus R McFarland; Michael S Okun
Journal:  J Neurol       Date:  2012-09-25       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.